Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
FAPI PET has been developed as a promising approach for the evaluation of fibroinflammatory, such as in inflammatory bowel disease. This prospective study aims to explore the value of 18F-AlF-FAPI PET/CT in assessing the activity of Thyroid Eye Disease (TED) and investigate whether FAPI PET/CT may be superior to 99mTc-DTPA SPECT/CT for the diagnosis, therapy response assessment, and follow-up of TED.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: t
View:
• Age ≥ 18 years;
• Patients diagnosed with TED;
• Complete understanding and voluntary participation in this study, with the signing of an informed consent form.
Locations
Other Locations
China
Dept. of Nuclear Medicine, Peking University Third Hospital
RECRUITING
Beijing
Contact Information
Primary
Hui Li, Dr.
huilee1990@163.com
86-13121136769
Backup
Lingge Suo, Dr.
suolingge_1019@126.com
86-010-82264935
Time Frame
Start Date: 2023-12-15
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 50
Treatments
Experimental: Experimental arm
Patients with TED will be recruited in the study.~Interventions:~Diagnostic Test: 18F-AlF-FAPI PET/CT and 99mTc-DTPA SPECT/CT.
Related Therapeutic Areas
Sponsors
Leads: Peking University Third Hospital